日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial

胃肠道肿瘤中新抗原特异性肿瘤浸润淋巴细胞:一项 II 期试验

Lowery, Frank J; Goff, Stephanie L; Gasmi, Billel; Parkhurst, Maria R; Ratnam, Nivedita M; Halas, Hyunmi K; Shelton, Thomas E; Langhan, Michelle M; Bhasin, Aarushi; Dinerman, Aaron J; Dulemba, Victoria; Goldlust, Ian S; Gustafson, Alexandra M; Hakim, Abraham A; Hitscherich, Kyle J; Kenney, Lisa M; Levy, Lior; Rault-Wang, Juliette G; Bera, Alakesh; Ray, Satyajit; Seavey, Courtney D; Hoang, Chuong D; Hernandez, Jonathan M; Gartner, Jared J; Sindiri, Sivasish; Prickett, Todd D; McIntyre, Lori S; Krishna, Sri; Robbins, Paul F; Klemen, Nicholas D; Kwong, Mei Li M; Yang, James C; Rosenberg, Steven A

Dual Immune Check Point Blockade in MGMT-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial

双重免疫检查点阻断治疗MGMT未甲基化新诊断的胶质母细胞瘤:NRG Oncology BN007,一项随机II/III期临床试验

Lassman, Andrew B; Polley, Mei-Yin C; Iwamoto, Fabio M; Sloan, Andrew E; Wang, Tony J C; Aldape, Kenneth D; Wefel, Jeffrey S; Gondi, Vinai; Gutierrez, Alonso N; Manasawala, Mohammed H; Gilbert, Mark R; Sulman, Erik P; Wolchok, Jedd D; Green, Richard M; Neil, Elizabeth C; Lukas, Rimas V; Goldlust, Samuel A; Snuderl, Matija; Galbraith, Kristyn; Dignam, James J; Won, Minhee; Mehta, Minesh P

November Industry News

11月行业新闻

Goldlust, Ian S; Gormally, Michael V; Teichholtz, Sara; Turriff, Amy E; Harding, James J; Bianchi, Diana W; McCartney, Fiona

Recent advances in Tumor Treating Fields (TTFields) therapy for glioblastoma

胶质母细胞瘤肿瘤电场治疗(TTFields)的最新进展

Khagi, Simon; Kotecha, Rupesh; Gatson, Na Tosha N; Jeyapalan, Suriya; Abdullah, Huda Ismail; Avgeropoulos, Nicholas G; Batzianouli, Eleni T; Giladi, Moshe; Lustgarten, Leonardo; Goldlust, Samuel A

Reporting patterns of multiple sclerosis with immune checkpoint inhibitors: analysis of the FDA Adverse Event Reporting System

免疫检查点抑制剂治疗多发性硬化症的报告模式:FDA不良事件报告系统分析

Shirani, Afsaneh; Goldlust, Samuel A; Stuve, Olaf

Prenatal cfDNA Sequencing and Incidental Detection of Maternal Cancer

产前cfDNA测序和母体癌症的意外发现

Turriff, Amy E; Annunziata, Christina M; Malayeri, Ashkan A; Redd, Bernadette; Pavelova, Miroslava; Goldlust, Ian S; Rajagopal, Padma Sheila; Lin, Jielu; Bianchi, Diana W

Phase 1 trial of TPI 287, a microtubule stabilizing agent, in combination with bevacizumab in adults with recurrent glioblastoma

TPI 287(一种微管稳定剂)联合贝伐单抗治疗复发性胶质母细胞瘤成人患者的 I 期临床试验

Goldlust, Samuel A; Nabors, Louis B; Hsu, Sigmund; Mohile, Nimish; Duic, Paul J; Benkers, Tara; Singer, Samuel; Rao, Mayank; Cappello, Lori; Silberman, Sandra L; Farmer, George

CTNI-30. A PHASE 2 DOUBLE-BLIND, RANDOMIZED, PROSPECTIVE, PLACEBO CONTROLLED STUDY OF NANO₂TM COMBINED WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA: RESTORE

CTNI-30。一项针对新诊断胶质母细胞瘤患者的 NANO₂™ 联合放射治疗和替莫唑胺治疗的 II 期双盲、随机、前瞻性、安慰剂对照研究:RESTOR

Cordero, Raúl R; Feron, Sarah; Damiani, Alessandro; MacDonell, Shelley; Carrasco, Jorge; Pizarro, Jaime; Karas, Cyrus; Jorquera, Jose; Sepulveda, Edgardo; Cabello, Fernanda; Fernandoy, Francisco; Wang, Chenghao; Khan, Alia L; Casassa, Gino; Lujan, Arturo; Chakrabarti, Jayati; Eschbacher, Jennifer; Zada, Gabriel; Kim, Albert; Little, Andrew; Santagata, Sandro; Zavros, Yana; Badruddoja, Michael A; Placencia, Crystal; Unger, Evan; Gellert, Scott; Stea, Baldassarre; Peters, Katherine B; Kong, Xiao-Tang; Aiken, Robert; Goldin, Caroline; Mahadevan, Daruka; Goldlust, Samuel A

PARP inhibitors in ovarian cancer

PARP抑制剂在卵巢癌中的应用

Goldlust, Ian S; Guidice, Elena; Lee, Jung-Min

Preoperative anemia is associated with prolonged hospital stay and increased facility discharges after glioblastoma resection

术前贫血与胶质母细胞瘤切除术后住院时间延长和出院率增加相关。

Almekkawi, Ahmad K; Adenwalla, Ammar; Caruso, James P; Hicks, William H; Rail, Benjamin; Bagley, Carlos A; Breshears, Jonathan D; El Ahmadieh, Tarek Y; Garzon-Muvdi, Tomas; Goldlust, Samuel A